STEFFANY KUPIEC: Open Payments
NPI 1740537190 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 16 payments from 7 companies in 2025. Trend: 2023 $166 · 2024 $244 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $91 |
| Ascendis Pharma Endocrinology Inc | 3 | $73 |
| Corcept Therapeutics | 2 | $63 |
| Lilly USA, LLC | 3 | $62 |
| Dexcom, Inc. | 2 | $41 |
| Medtronic, Inc. | 1 | $33 |
| Tandem Diabetes Care, Inc. | 1 | $28 |
Products named: Ozempic, Yorvipath, Korlym, MOUNJARO, Dexcom G6 Transmitter, MINIMED 780G, t:slim X2 Insulin Pump with Control-IQ, Wegovy.
Industry payments across OH — which companies pay providers there.
